The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI).
about
Estrogen-cholinergic interactions: Implications for cognitive agingImpact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plansGenetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkersAPOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis.The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.APOE Genotype Effects on Intrinsic Brain Network Connectivity in Patients with Amnestic Mild Cognitive Impairment.Conversion Discriminative Analysis on Mild Cognitive Impairment Using Multiple Cortical Features from MR Images.Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early InterventionAdverse Effects of the Apolipoprotein E ε4 Allele on Episodic Memory, Task Switching and Gray Matter Volume in Healthy Young AdultsSmoking and increased Alzheimer's disease risk: a review of potential mechanismsAPOE and COMT polymorphisms are complementary biomarkers of status, stability, and transitions in normal aging and early mild cognitive impairment.Association of cancer history with Alzheimer's disease onset and structural brain changes.The relationship between regional brain volumes and the extent of coronary artery disease in mild cognitive impairmentCoronary artery disease and plasma apolipoprotein E4 in mild cognitive impairment.Synergistic associations of catechol-O-methyltransferase and brain-derived neurotrophic factor with executive function in aging are selective and modified by apolipoprotein E.Cerebral cortical Aβ42 and PHF-τ in 325 consecutive brain autopsies stratified by diagnosis, location, and APOE.Cerebral hypometabolism and grey matter density in MAPT intron 10 +3 mutation carriersApolipoprotein E polymorphism is associated with susceptibility to schizophrenia among Saudis.Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults.APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concernNetwork-based analysis of genetic variants associated with hippocampal volume in Alzheimer's disease: a study of ADNI cohorts.Cholinergic Enhancement of Brain Activation in Mild Cognitive Impairment during Episodic Memory EncodingAssociation Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older AdultsNeuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future research.The effect of the top 20 Alzheimer disease risk genes on gray-matter density and FDG PET brain metabolism.Genome-wide association study of language performance in Alzheimer's disease.Interaction of Cigarette Smoking History With APOE Genotype and Age on Amyloid Level, Glucose Metabolism, and Neurocognition in Cognitively Normal Elders.Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer's DiseaseProgression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort.Network Diffusion Model of Progression Predicts Longitudinal Patterns of Atrophy and Metabolism in Alzheimer's Disease.Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 Genotype.Therapeutic efficacy of the Ginkgo special extract EGb761® within the framework of the mitochondrial cascade hypothesis of Alzheimer's disease.State of Play in Alzheimer's Disease Genetics.Human ApoE ɛ2 Promotes Regulatory Mechanisms of Bioenergetic and Synaptic Function in Female Brain: A Focus on V-type H+-ATPase.Structural and resting-state MRI detects regional brain differences in young and mid-age healthy APOE-e4 carriers compared with non-APOE-e4 carriers.Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'.Type 2 diabetes mellitus is associated with brain atrophy and hypometabolism in the ADNI cohort.Biomarkers in neurodegenerative disorders: translating research into clinical practice.
P2860
Q26799402-7811CCB6-4A3D-493C-A3BB-8F76DC266C30Q26801629-114CA5AC-50F9-4460-BA73-24D08E2B4A2FQ26801647-DD15C132-F1C8-44C1-9770-967E786885CDQ28542010-DB4B0B2E-4D76-4DA7-B01C-CF8EDC4224FEQ30823419-EAD117D1-41FD-484D-B4CB-62F2AEDA6F66Q30874688-3CF94179-AF92-436B-9BCD-3B3973CE8B76Q30971403-F4AD5CB0-E2A1-45E8-B5A1-43821C3AE436Q33671934-A5879067-8C3B-42E7-883A-00479C7241F4Q33701135-B30A24C6-B4BC-404E-BDD8-2761E0A3015CQ33838291-CC184683-B5E0-4264-8899-00D4F611E58CQ33849832-6A072705-AE42-48D8-BD8E-3746279DD086Q33902721-90071F3D-F693-4356-BA5F-93B69030A879Q34139700-67B189EB-A5AE-44B1-8CD5-892135C2060DQ34433766-1D8C8752-98E4-4EE3-BC74-A7B5DEAF143BQ34529816-EBA3490D-C856-4472-82F1-439F368E5B77Q34609138-9685EDB1-6711-401A-A6B9-19F16E015010Q34717480-C7F707E0-1D5C-44B6-ADAF-74BE3EAB5541Q34963974-7473E861-2115-4A04-8232-B0256D40E9D0Q34987511-07EB5B90-DC25-494F-903D-37B20258733FQ35992151-082C0561-4FC7-4E94-819B-476C7E76D956Q36035069-8811EBEE-C0BD-42B2-AA07-6D2949B0B1CEQ36259716-132DD614-2266-47FB-B4C5-725C70D5A7F7Q36476089-BAD21B70-1A83-4A96-A463-E12F77DECB49Q37178317-69E81BE4-8641-43F5-9745-7A246824425EQ37268405-3A3CB7B2-BA7D-4F2A-8ABB-4E174E19F447Q37540122-B5248384-037B-4D94-8AF0-745C3A8CF014Q37544199-759F5F95-423A-4BBA-8FEA-D9AF87F208DFQ38376090-0780B5B7-E8E1-49BD-B2AB-DAB9A1ED8DE0Q38413816-8F9F9BB6-A6D8-4219-9819-45EBA9C6AEF8Q38760663-639A6195-93E8-4A96-9DD2-6629BDAA0F2DQ38824785-DCBFA0C6-70EC-484E-9846-EA970BB5E781Q39054090-6E0AD3D1-120C-4AF4-89B2-0E6890E78A44Q39189440-1F0F1742-8AC0-43F7-91C9-0FF7AFB9A6F0Q39275834-6D19D0E3-BDBD-4763-AA3C-C9B196DD99F7Q39307376-0A8B1C08-7E8E-4C14-BA4D-70DF46046730Q39657626-F9A2DFAA-4447-4079-98D6-BEB57131515CQ39958025-257D2F70-326F-4C67-8982-09C4D57B4189Q40873275-AC6FF20C-243A-4D92-9052-2A911E6496E2Q42373062-3634E314-F8FC-46C6-B356-F967DF016FC2Q42953514-B8BA5D36-9C85-451C-B286-EFAAD62AC860
P2860
The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI).
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI).
@ast
The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI).
@en
type
label
The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI).
@ast
The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI).
@en
prefLabel
The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI).
@ast
The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI).
@en
P2093
P2860
P50
P356
P1476
The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI).
@en
P2093
Alzheimer's Disease Neuroimaging Initiative (ADNI)†
Kwangsik Nho
Leslie M Shaw
Robert A Koeppe
William J Jagust
P2860
P356
10.3389/FNAGI.2013.00011
P407
P50
P577
2013-04-01T00:00:00Z